{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:36:30Z","timestamp":1786988190217,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports\u00ae"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ekir.2024.01.026","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T12:46:06Z","timestamp":1705581966000},"page":"951-959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Calciphylaxis Episodes in the Australia and New Zealand Dialysis and Transplant Registry"],"prefix":"10.1016","volume":"9","author":[{"given":"Nigel D.","family":"Toussaint","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bongetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ruderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grahame J.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel M.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rathika","family":"Krishnasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg J.","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janak R.","family":"De Zoysa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2024.01.026_bib1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2215\/CJN.00530108","article-title":"Calciphylaxis from nonuremic causes: a systematic review","volume":"3","author":"Nigwekar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.01.026_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2015.01.034","article-title":"Calciphylaxis: risk factors, diagnosis, and treatment","volume":"66","author":"Nigwekar","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.01.026_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.ASW.0000554443.14002.13","article-title":"Calciphylaxis: diagnosis, pathogenesis, and treatment","volume":"32","author":"Chang","year":"2019","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.ekir.2024.01.026_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ndt\/gfz256","article-title":"The Australian Calciphylaxis Registry: reporting clinical features and outcomes of patients with calciphylaxis","volume":"36","author":"Ruderman","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.01.026_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MNH.0000000000000328","article-title":"Calciphylaxis","volume":"26","author":"Nigwekar","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2024.01.026_bib6","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMra1505292","article-title":"Calciphylaxis","volume":"378","author":"Nigwekar","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2024.01.026_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/09546634.2019.1618435","article-title":"Calcific uremic arteriolopathy (calciphylaxis) calls into question the validity of guidelines of diagnosis and treatment","volume":"31","author":"Chiriac","year":"2020","journal-title":"J\u00a0Dermatol Treat"},{"key":"10.1016\/j.ekir.2024.01.026_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/ndt\/gfv438","article-title":"Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry","volume":"32","author":"Brandenburg","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.01.026_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.trre.2013.01.003","article-title":"Australian registries -ANZDATA and ANZOD","volume":"27","author":"McDonald","year":"2013","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.ekir.2024.01.026_bib10","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1681\/ASN.2015091065","article-title":"A\u00a0nationally representative study of calcific uremic arteriolopathy risk factors","volume":"27","author":"Nigwekar","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.01.026_bib11","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/ndt\/gfr658","article-title":"A\u00a0case-control study of calciphylaxis in Japanese end-stage renal disease patients","volume":"27","author":"Hayashi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.01.026_bib12","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s11255-017-1721-9","article-title":"Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy","volume":"49","author":"Santos","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ekir.2024.01.026_bib13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/ckj\/sfy007","article-title":"Multi-intervention management of calcific uremic arteriolopathy in 24 patients","volume":"11","author":"Harris","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2024.01.026_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12882-020-01722-y","article-title":"Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study","volume":"21","author":"Gaisne","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2024.01.026_bib15","article-title":"Prevalence and clinical characteristics of calciphylaxis in Chinese hemodialysis patients","volume":"9","author":"Liu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ekir.2024.01.026_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/nep.14156","article-title":"Clinical features and outcomes of calciphylaxis in Chinese patients with chronic kidney disease","volume":"28","author":"Jiao","year":"2023","journal-title":"Nephrol (Carlton)"},{"key":"10.1016\/j.ekir.2024.01.026_bib17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/ced.15009","article-title":"Calciphylaxis in uraemic and nonuraemic settings: clinical risk factors and histopathological findings","volume":"47","author":"Ababneh","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ekir.2024.01.026_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mayocpiqo.2022.12.006","article-title":"Patient-reported and clinical outcomes among patients with calciphylaxis","volume":"7","author":"Wen","year":"2023","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.ekir.2024.01.026_bib19","first-page":"1537","article-title":"Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study","volume":"34","author":"Chinnadurai","year":"2021","journal-title":"J\u00a0Nephrol"},{"issue":"suppl 3","key":"10.1016\/j.ekir.2024.01.026_bib20","doi-asserted-by":"crossref","first-page":"S724","DOI":"10.1007\/s11606-014-2910-1","article-title":"Quantifying a rare disease in administrative data: the example of calciphylaxis","volume":"29","author":"Nigwekar","year":"2014","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.ekir.2024.01.026_bib21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1523-1755.2001.00803.x","article-title":"Risk factors and mortality associated with calciphylaxis in end-stage renal disease","volume":"60","author":"Mazhar","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.01.026_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ckj\/sfab205","article-title":"Development of calciphylaxis in kidney transplant recipients with a functioning graft","volume":"15","author":"Guill\u00e9n-Olmos","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2024.01.026_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ckj\/sfab117","article-title":"The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis","volume":"15","author":"Sinha","year":"2021","journal-title":"Clin Kidney J"}],"container-title":["Kidney International Reports\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924000366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924000366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:27:40Z","timestamp":1766449660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024924000366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2468024924000366"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2024.01.026","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calciphylaxis Episodes in the Australia and New Zealand Dialysis and Transplant Registry","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports\u00ae","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2024.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}